AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 59 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $60,681 | -28.6% | 25,496 | +57.6% | 0.00% | – |
| Q4 2021 | $85,000 | -95.7% | 16,178 | -94.6% | 0.00% | -100.0% |
| Q2 2021 | $1,977,000 | +248.1% | 297,749 | +200.7% | 0.01% | +200.0% |
| Q1 2021 | $568,000 | +158.2% | 99,013 | +624.2% | 0.00% | +50.0% |
| Q2 2020 | $220,000 | -92.4% | 13,672 | -97.2% | 0.00% | -93.1% |
| Q1 2020 | $2,907,000 | -67.6% | 485,229 | -28.7% | 0.03% | -53.2% |
| Q4 2019 | $8,978,000 | +42.6% | 680,181 | +34.2% | 0.06% | +24.0% |
| Q3 2019 | $6,297,000 | -24.1% | 507,007 | -1.6% | 0.05% | -26.5% |
| Q2 2019 | $8,298,000 | -43.4% | 515,405 | +10.6% | 0.07% | -1.4% |
| Q1 2019 | $14,660,000 | +270.7% | 465,862 | +286.8% | 0.07% | +72.5% |
| Q4 2018 | $3,955,000 | – | 120,442 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $49,738,112 | 74.10% |
| TFG Asset Management GP Ltd | 12,000,000 | $27,960,000 | 5.10% |
| Paradigm Biocapital Advisors LP | 14,406,782 | $33,567,802 | 2.28% |
| Lynx1 Capital Management LP | 1,363,025 | $3,175,848 | 2.10% |
| Deep Track Capital, LP | 15,000,000 | $34,950,000 | 1.35% |
| Affinity Asset Advisors, LLC | 1,992,466 | $4,642,446 | 1.31% |
| DAFNA Capital Management LLC | 928,253 | $2,162,829 | 0.67% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $8,730,177 | 0.58% |
| ARMISTICE CAPITAL, LLC | 6,900,000 | $16,077,000 | 0.25% |
| Blackstone Inc. | 20,485,611 | $47,731,474 | 0.20% |